{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:44:04Z","timestamp":1785851044220,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01897-4","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:49:18Z","timestamp":1785847758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting FOSL1-KCa3.1 inhibits ferroptosis and cartilage destruction by suppressing mitochondrial hyperfusion"],"prefix":"10.1038","author":[{"given":"Ren-peng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-cai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"1897_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023\u201338.","journal-title":"Lancet"},{"key":"1897_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41584-024-01169-7","volume":"20","author":"V Konzett","year":"2024","unstructured":"Konzett V, Aletaha D. Management strategies in rheumatoid arthritis. Nat Rev Rheumatol. 2024;20:760\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"1897_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrrheum.2014.157","volume":"11","author":"EA Makris","year":"2015","unstructured":"Makris EA, Gomoll AH, Malizos KN, Hu JC, Athanasiou KA. Repair and tissue engineering techniques for articular cartilage. Nat Rev Rheumatol. 2015;11:21\u201334.","journal-title":"Nat Rev Rheumatol"},{"key":"1897_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41413-025-00430-3","volume":"13","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Liu L, Ti H, Chen M, Chen Y, Du D, et al. Synovial fibroblast-derived small extracellular vesicles miRNA15-29148 promote articular chondrocyte apoptosis in rheumatoid arthritis. Bone Res. 2025;13:61.","journal-title":"Bone Res"},{"key":"1897_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60037-4","volume":"16","author":"Z Mei","year":"2025","unstructured":"Mei Z, Yilamu K, Ni W, Shen P, Pan N, Chen H, et al. Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nat Commun. 2025;16:4892.","journal-title":"Nat Commun"},{"key":"1897_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58059-z","volume":"16","author":"H He","year":"2025","unstructured":"He H, Zhang Q, Zhang Y, Qu S, Li B, Lin J, et al. Injectable bioadhesive and lubricating hydrogel with polyphenol-mediated single-atom nanozyme for rheumatoid arthritis therapy. Nat Commun. 2025;16:2768.","journal-title":"Nat Commun"},{"key":"1897_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"1897_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1897_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41584-024-01146-0","volume":"20","author":"R Zhou","year":"2024","unstructured":"Zhou R, Fu W, Vasylyev D, Waxman SG, Liu CJ. Ion channels in osteoarthritis: emerging roles and potential targets. Nat Rev Rheumatol. 2024;20:545\u201364.","journal-title":"Nat Rev Rheumatol"},{"key":"1897_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-023-06888-7","volume":"625","author":"W Fu","year":"2024","unstructured":"Fu W, Vasylyev D, Bi Y, Zhang M, Sun G, Khleborodova A, et al. Na(v)1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. Nature. 2024;625:557\u201365.","journal-title":"Nature"},{"key":"1897_CR11","doi-asserted-by":"publisher","first-page":"49085","DOI":"10.1074\/jbc.M307508200","volume":"278","author":"Y Xu","year":"2003","unstructured":"Xu Y, Tuteja D, Zhang Z, Xu D, Zhang Y, Rodriguez J, et al. Molecular identification and functional roles of a Ca2+-activated K+ channel in human and mouse hearts. J Biol Chem. 2003;278:49085\u201394.","journal-title":"J Biol Chem"},{"key":"1897_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0043-z","volume":"50","author":"M Gu","year":"2018","unstructured":"Gu M, Zhu Y, Yin X, Zhang DM. Small-conductance Ca2+-activated K+ channels: insights into their roles in cardiovascular disease. Exp Mol Med. 2018;50:1\u20137.","journal-title":"Exp Mol Med"},{"key":"1897_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21:85\u2013100.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1897_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fneur.2019.00282","volume":"10","author":"A Alizadeh","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019;10:282.","journal-title":"Front Neurol"},{"key":"1897_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cells9061505","volume":"9","author":"AM Battaglia","year":"2020","unstructured":"Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and cancer: mitochondria meet the \u201cIron Maiden\u201d cell death. Cells. 2020;9:1505.","journal-title":"Cells"},{"key":"1897_CR16","doi-asserted-by":"publisher","first-page":"e202105043","DOI":"10.1083\/jcb.202105043","volume":"220","author":"B Gan","year":"2021","unstructured":"Gan B. Mitochondrial regulation of ferroptosis. J Cell Biol. 2021;220:e202105043.","journal-title":"J Cell Biol"},{"key":"1897_CR17","doi-asserted-by":"publisher","first-page":"eabn4705","DOI":"10.1126\/science.abn4705","volume":"379","author":"R Iwata","year":"2023","unstructured":"Iwata R, Casimir P, Erkol E, Boubakar L, Planque M, Gallego L\u00f3pez IM, et al. Mitochondrial metabolism sets the species-specific tempo of neuronal development. Science. 2023;379:eabn4705.","journal-title":"Science"},{"key":"1897_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tins.2022.12.001","volume":"46","author":"JJ Collier","year":"2023","unstructured":"Collier JJ, Olahova M, McWilliams TG, Taylor RW. Mitochondrial signalling and homeostasis: from cell biology to neurological disease. Trends Neurosci. 2023;46:137\u201352.","journal-title":"Trends Neurosci"},{"key":"1897_CR19","first-page":"76","volume":"12","author":"XX Fan","year":"2020","unstructured":"Fan XX, Xu MZ, Leung EL, Jun C, Yuan Z, Liu L. ROS-responsive berberine polymeric micelles effectively suppressed the inflammation of rheumatoid arthritis by targeting mitochondria. Nanomicro Lett. 2020;12:76.","journal-title":"Nanomicro Lett"},{"key":"1897_CR20","first-page":"503","volume":"15","author":"QH Phua","year":"2024","unstructured":"Phua QH, Ng SY, Soh BS. Mitochondria: a potential rejuvenation tool against aging. Aging Dis. 2024;15:503\u201316.","journal-title":"Aging Dis"},{"key":"1897_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.14336\/AD.2023.0717","volume":"15","author":"F Feng","year":"2024","unstructured":"Feng F, He S, Li X, He J, Luo L. Mitochondria-mediated ferroptosis in diseases therapy: from molecular mechanisms to implications. Aging Dis. 2024;15:714\u201338.","journal-title":"Aging Dis"},{"key":"1897_CR22","first-page":"32","volume":"11","author":"BH Liu","year":"2024","unstructured":"Liu BH, Xu CZ, Liu Y, Lu ZL, Fu TL, Li GR, et al. Mitochondrial quality control in human health and disease. Mil Med Res. 2024;11:32.","journal-title":"Mil Med Res"},{"key":"1897_CR23","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1080\/15548627.2020.1848130","volume":"17","author":"CJ Choong","year":"2021","unstructured":"Choong CJ, Okuno T, Ikenaka K, Baba K, Hayakawa H, Koike M, et al. Alternative mitochondrial quality control mediated by extracellular release. Autophagy. 2021;17:2962\u201374.","journal-title":"Autophagy"},{"key":"1897_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013;20:31\u201342.","journal-title":"Cell Death Differ"},{"key":"1897_CR25","doi-asserted-by":"publisher","unstructured":"Huang C, Yi H, Shi Y, Cao Q, Shi Y, Cheng D, et al.\u00a0KCa3.1 mediates dysregulation of mitochondrial quality control in diabetic kidney disease.\u00a0Front Cell Dev Biol. 2021;9:573814. https:\/\/doi.org\/10.3389\/fcell.2021.573814.","DOI":"10.3389\/fcell.2021.573814"},{"key":"1897_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gene.2017.11.034","volume":"642","author":"RP Zhou","year":"2018","unstructured":"Zhou RP, Ni WL, Dai BB, Wu XS, Wang ZS, Xie YY, et al. ASIC2a overexpression enhances the protective effect of PcTx1 and APETx2 against acidosis-induced articular chondrocyte apoptosis and cytotoxicity. Gene. 2018;642:230\u201340.","journal-title":"Gene"},{"key":"1897_CR27","doi-asserted-by":"publisher","first-page":"698679","DOI":"10.3389\/fcell.2021.698679","volume":"9","author":"C Li","year":"2021","unstructured":"Li C, Liu J, Hou W, Kang R, Tang D. STING1 promotes ferroptosis through MFN1\/2-dependent mitochondrial fusion. Front Cell Dev Biol. 2021;9:698679.","journal-title":"Front Cell Dev Biol"},{"key":"1897_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1897_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"1897_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103255","volume":"75","author":"Z Feng","year":"2024","unstructured":"Feng Z, Meng F, Huo F, Zhu Y, Qin Y, Gui Y, et al. Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1\/TLR4\/STAT3 axis in M1 macrophages. Redox Biol. 2024;75:103255.","journal-title":"Redox Biol"},{"key":"1897_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.779585","volume":"13","author":"T Zhao","year":"2022","unstructured":"Zhao T, Yang Q, Xi Y, Xie Z, Shen J, Li Z, et al. Ferroptosis in rheumatoid arthritis: a potential therapeutic strategy. Front Immunol. 2022;13:779585.","journal-title":"Front Immunol"},{"key":"1897_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06300-0","volume":"23","author":"X Zhu","year":"2025","unstructured":"Zhu X, Lu H, Jia H, Wei X, Xue J, Li W, et al. Ferrostatin-1 reduces the inflammatory response of rheumatoid arthritis by decreasing the antigen- presenting function of fibroblast-like synoviocytes. J Transl Med. 2025;23:280.","journal-title":"J Transl Med"},{"key":"1897_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156493","volume":"139","author":"Y Li","year":"2025","unstructured":"Li Y, Li A, Xing Y, Jiang Y, Pei H, He Z, et al. Gastrodin targets the system Xc-\/GPX4 axis to inhibit abnormal proliferation of fibroblast-like synoviocytes and improve rheumatoid arthritis. Phytomedicine. 2025;139:156493.","journal-title":"Phytomedicine"},{"key":"1897_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412817","volume":"12","author":"D Wang","year":"2025","unstructured":"Wang D, Pan Y, Chen W, He D, Qi W, Chen J, et al. Nanodrugs targeting key factors of ferroptosis regulation for enhanced treatment of osteoarthritis. Adv Sci. 2025;12:e2412817.","journal-title":"Adv Sci"},{"key":"1897_CR35","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10067-014-2597-z","volume":"33","author":"S Datta","year":"2014","unstructured":"Datta S, Kundu S, Ghosh P, De S, Ghosh A, Chatterjee M. Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clin Rheumatol. 2014;33:1557\u201364.","journal-title":"Clin Rheumatol"},{"key":"1897_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF00290523","volume":"15","author":"P Fritz","year":"1996","unstructured":"Fritz P, Saal JG, Wicherek C, Konig A, Laschner W, Rautenstrauch H. Quantitative photometrical assessment of iron deposits in synovial membranes in different joint diseases. Rheumatol Int. 1996;15:211\u20136.","journal-title":"Rheumatol Int"},{"key":"1897_CR37","first-page":"30","volume":"7","author":"DJ Ogilvie-Harris","year":"1980","unstructured":"Ogilvie-Harris DJ, Fornaiser VL. Synovial iron deposition in osteoarthritis and rheumatoid arthritis. J Rheumatol. 1980;7:30\u20136.","journal-title":"J Rheumatol"},{"key":"1897_CR38","first-page":"147","volume":"39","author":"C Zhao","year":"2023","unstructured":"Zhao C, Sun G, Li Y, Kong K, Li X, Kan T, et al. Forkhead box O3 attenuates osteoarthritis by suppressing ferroptosis through inactivation of NF-kappaB\/MAPK signaling. J Orthop Transl. 2023;39:147\u201362.","journal-title":"J Orthop Transl"},{"key":"1897_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.matbio.2018.05.005","volume":"71-72","author":"Y Krishnan","year":"2018","unstructured":"Krishnan Y, Grodzinsky AJ. Cartilage diseases. Matrix Biol. 2018;71-72:51\u201369.","journal-title":"Matrix Biol"},{"key":"1897_CR40","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.joca.2023.04.003","volume":"31","author":"M Arra","year":"2023","unstructured":"Arra M, Abu-Amer Y. Cross-talk of inflammation and chondrocyte intracellular metabolism in osteoarthritis. Osteoarthr Cartil. 2023;31:1012\u201321.","journal-title":"Osteoarthr Cartil"},{"key":"1897_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997621","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhao YJ, Zhang HL, Hao WJ, Zhu RD, Wang Y, et al. Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis. Front Immunol. 2022;13:997621.","journal-title":"Front Immunol"},{"key":"1897_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1897_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05463-8","volume":"13","author":"M Bachmann","year":"2022","unstructured":"Bachmann M, Rossa A, Varanita T, Fioretti B, Biasutto L, Milenkovic S, et al. Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo. Cell Death Dis. 2022;13:1055.","journal-title":"Cell Death Dis"},{"key":"1897_CR44","doi-asserted-by":"publisher","first-page":"RP87561","DOI":"10.7554\/eLife.87561.3","volume":"12","author":"H Kang","year":"2024","unstructured":"Kang H, Choi SW, Kim JY, Oh SJ, Kim SJ, Lee MS. ER-to-lysosome Ca2+ refilling followed by K+ efflux-coupled store-operated Ca2+ entry in inflammasome activation and metabolic inflammation. Elife. 2024;12:RP87561.","journal-title":"Elife"},{"key":"1897_CR45","doi-asserted-by":"publisher","first-page":"178738","DOI":"10.1016\/j.ejphar.2026.178738","volume":"1019","author":"J Xing","year":"2026","unstructured":"Xing J, Li YG, Zhang YF, Yu P, Cheng N, Wang K, et al. Blockade of KCa3.1 ameliorates rheumatoid arthritis by suppressing macrophage M1 polarization via the NLRP3 inflammasome signaling pathway. Eur J Pharmacol. 2026;1019:178738.","journal-title":"Eur J Pharm"},{"key":"1897_CR46","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.celrep.2015.01.030","volume":"10","author":"H Antonicka","year":"2015","unstructured":"Antonicka H, Shoubridge EA. Mitochondrial RNA granules are centers for posttranscriptional RNA processing and ribosome biogenesis. Cell Rep. 2015;10:920\u201332.","journal-title":"Cell Rep"},{"key":"1897_CR47","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Jia YC, Ding YX, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19:2756\u201371.","journal-title":"Int J Biol Sci"},{"key":"1897_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102304","volume":"52","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Krantz S, Qin X, Li S, Gunasekara H, Kim YM, et al. Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy. Redox Biol. 2022;52:102304.","journal-title":"Redox Biol"},{"key":"1897_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333.","journal-title":"Signal Transduct Target Ther"},{"key":"1897_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jhep.2021.03.028","volume":"75","author":"A Vallejo","year":"2021","unstructured":"Vallejo A, Erice O, Entrialgo-Cadierno R, Feliu I, Guruceaga E, Perugorria MJ, et al. FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted. J Hepatol. 2021;75:363\u201376.","journal-title":"J Hepatol"},{"key":"1897_CR51","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.4161\/cc.6.21.4850","volume":"6","author":"P Verde","year":"2007","unstructured":"Verde P, Casalino L, Talotta F, Yaniv M, Weitzman JB. Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters. Cell Cycle. 2007;6:2633\u20139.","journal-title":"Cell Cycle"},{"key":"1897_CR52","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.ymthe.2021.10.028","volume":"30","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wang S, Li HL, Luo H, Wu X, Lu J, et al. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9\/CYLD\/NF-kappaB axis. Mol Ther. 2022;30:2568\u201383.","journal-title":"Mol Ther"},{"key":"1897_CR53","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1172\/JCI96832","volume":"129","author":"N Hannemann","year":"2019","unstructured":"Hannemann N, Cao S, Eriksson D, Schnelzer A, Jordan J, Eberhardt M, et al. Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis. J Clin Invest. 2019;129:2669\u201384.","journal-title":"J Clin Invest."},{"key":"1897_CR54","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4161\/cc.8.10.8411","volume":"8","author":"S Shiozawa","year":"2009","unstructured":"Shiozawa S, Tsumiyama K. Pathogenesis of rheumatoid arthritis and c-Fos\/AP-1. Cell Cycle. 2009;8:1539\u201343.","journal-title":"Cell Cycle"},{"key":"1897_CR55","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI119277","volume":"99","author":"S Shiozawa","year":"1997","unstructured":"Shiozawa S, Shimizu K, Tanaka K, Hino K. Studies on the contribution of c-fos\/AP-1 to arthritic joint destruction. J Clin Invest. 1997;99:1210\u20136.","journal-title":"J Clin Invest"},{"key":"1897_CR56","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","volume":"27","author":"MP Mattson","year":"2018","unstructured":"Mattson MP, Arumugam TV. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metab. 2018;27:1176\u201399.","journal-title":"Cell Metab"},{"key":"1897_CR57","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1172\/JCI0215582","volume":"110","author":"K Redlich","year":"2002","unstructured":"Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest. 2002;110:1419\u201327.","journal-title":"J Clin Invest"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01897-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:49:20Z","timestamp":1785847760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01897-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":57,"alternative-id":["1897"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01897-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The corresponding author, Wei\u00a0Wei, is a member of the Editorial Board of the journal Acta Pharmacologica Sinica, but he has not been involved in the peer-review or decision-making process for this manuscript. Other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}